S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• SalicrúSRde La TorreJFVGil-MorenoAThe surgical management of early-stage cervical cancerCurr Opin Obstet Gynecol201325431231923787798
   PubMed Web of Science ®Google Scholar
• Al-MansourZVerschraegenCLocally advanced cervical cancer: what is the standard of care?Curr Opin Oncol201022550351220473164
   PubMed Web of Science ®Google Scholar
• NematbakhshMPezeshkiZEshraghi JaziFCisplatin-induced nephrotoxicity; protective supplements and gender differencesAsian Pac J Cancer Prev201718229531428345324
   PubMedGoogle Scholar
• ZhuHLuoHZhangWShenZHuXZhuXMolecular mechanisms of cisplatin resistance in cervical cancerDrug Des Devel Ther20161018851895
   PubMed Web of Science ®Google Scholar
• DonatoRCannonBRSorciGFunctions of S100 proteinsCurr Mol Med2013131245722834835
   PubMed Web of Science ®Google Scholar
• OdinkKCerlettiNBrüggenJTwo calcium-binding proteins in infiltrate macrophages of rheumatoid arthritisNature1987330614380823313057
   PubMed Web of Science ®Google Scholar
• KorndörferIPBruecknerFSkerraAThe crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteinsJ Mol Biol2007370588789817553524
   PubMed Web of Science ®Google Scholar
• MarenholzIHeizmannCWFritzGS100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclatureBiochem Biophys Res Commun200432241111112215336958
   PubMed Web of Science ®Google Scholar
• KällbergEVoglTLibergDS100A9 interaction with TLR4 promotes tumor growthPLoS One201273e3420722470535
   PubMed Web of Science ®Google Scholar
• LeandersonTLibergDIvarsFS100A9 as a pharmacological target molecule in inflammation and cancerEndocr Metab Immune Disord Drug Targets20151529710425772177
   PubMed Web of Science ®Google Scholar
• JinLShenQDingSJiangWJiangLZhuXImmunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapyGynecol Oncol2012126114014622487537
   PubMed Web of Science ®Google Scholar
• ZhuHPeiHPZengSProfiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinomaJ Proteome Res2009883969397619507834
   PubMed Web of Science ®Google Scholar
• ZhangWChenMChengHShenQWangYZhuXThe role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivoCancer Manag Res20181032333829497331
   PubMed Web of Science ®Google Scholar
• MarkowitzJCarsonWE3rdReview of S100A9 biology and its role in cancerBiochim Biophys Acta20131835110010923123827
   PubMed Web of Science ®Google Scholar
• YangWSMoonHGKimHSProteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancerJ Proteome Res20121121078108822074005
   PubMed Web of Science ®Google Scholar
• ZhuHWuTCChenWQRoles of galectin-7 and S100A9 in cervical squamous carcinoma: clinicopathological and in vitro evidenceInt J Cancer201313251051105922864818
   PubMed Web of Science ®Google Scholar
• ZhouZLiZSunZS100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabineSci Rep201662369527021626
   PubMed Web of Science ®Google Scholar
• HsuYLHungJYTsaiEMBenzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9Oncol Rep20153462889290026397389
   PubMed Web of Science ®Google Scholar
• KimWTKimJYanCS100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapyAnn Oncol201425597497924631944
   PubMed Web of Science ®Google Scholar
• JuWYooBCKimIJKimJWKimSCLeeHPIdentification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarraysOncol Res2009182–3475620066894
   PubMed Web of Science ®Google Scholar
• CiarimboliGMembrane transporters as mediators of cisplatin effects and side effectsScientifica201220124738291824278698
   PubMedGoogle Scholar
• KilicUSahinKTuzcuMEnhancement of cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallateFront Nutr201412825988128
   PubMedGoogle Scholar
• TungMCLinPLChengYWReduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2Oncotarget2016722323623237427083050
   PubMedGoogle Scholar
• ChenXZhangYShiYmiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2Int J Oncol20154741603161126323558
   PubMed Web of Science ®Google Scholar
• LiuJYangLZhangJKnock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expressionBMC Cancer20121237022920753
   PubMed Web of Science ®Google Scholar
• JingZHengWXiaLDownregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3Cancer Biol Ther201516454154825719555
   PubMed Web of Science ®Google Scholar
• WinterSSRicciJLuoLATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemiaHealth201355A4150
   PubMedGoogle Scholar
• LuJFPokharelDBebawyMMRP1 and its role in anticancer drug resistanceDrug Metab Rev201547440641926541366
   PubMed Web of Science ®Google Scholar
• AbdallahHMAl-AbdAMEl-DineRSEl-HalawanyAMP-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a reviewJ Adv Res201561456225685543
   PubMed Web of Science ®Google Scholar
• BouhamyiaLChantot-BastaraudSZaidiSImmunolocalization and cell expression of lung resistance-related protein (LRP) in normal and tumoral human respiratory cellsJ Histochem Cytochem200755877378217438350
   PubMed Web of Science ®Google Scholar
• DaltonWSScheperRJLung resistance-related protein: determining its role in multidrug resistanceJ Natl Cancer Inst199991191604160510511581
   PubMedGoogle Scholar
• KrishnakumarSMallikarjunaKDesaiNMultidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastomaBr J Ophthalmol200488121521152615548804
   PubMed Web of Science ®Google Scholar
• SchefferGLWijngaardPLFlensMJThe drug resistance- related protein LRP is the human major vault proteinNat Med1995165785827585126
   PubMed Web of Science ®Google Scholar
• ZhangYZhouTDuanJXiaoZLiGXuFInhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cellsBiomed Pharmacother201367875776223731711
   PubMed Web of Science ®Google Scholar
• MaoZPZhaoLJZhouSHLiuMQTanWFYaoHTExpression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinomaOncol Lett20159280681025621055
   PubMed Web of Science ®Google Scholar
• SohYGotoSKitajimaMNuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancersClin Oncol2005174264270
   Web of Science ®Google Scholar
• TownsendDMTewKDThe role of glutathione-S-transferase in anti- cancer drug resistanceOncogene200322477369737514576844
   PubMed Web of Science ®Google Scholar
• EijkelenboomABurgeringBMFOXOs: signalling integrators for homeostasis maintenanceNat Rev Mol Cell Biol2013142839723325358
   PubMed Web of Science ®Google Scholar
• Coomans de BrachèneADemoulinJBFOXO transcription factors in cancer development and therapyCell Mol Life Sci20167361159117226686861
   PubMed Web of Science ®Google Scholar
• MonsalveMOlmosYThe complex biology of FOXOCurr Drug Targets20111291322135021443460
   PubMed Web of Science ®Google Scholar
• YadavRKChauhanASZhuangLGanBFoxO transcription factors in cancer metabolismSemin Cancer Biol201850657629309929
   PubMed Web of Science ®Google Scholar
• XingYQLiAYangYLiXXZhangLNGuoHCThe regulation of FOXO1 and its role in disease progressionLife Sci201819312413129158051
   PubMed Web of Science ®Google Scholar
• ZhangXYalcinSLeeDFFOXO1 is an essential regulator of pluripotency in human embryonic stem cellsNat Cell Biol20111391092109921804543
   PubMed Web of Science ®Google Scholar
• ArdenKCFoxOs in tumor suppression and stem cell maintenanceCell2007128223523717254960
   PubMed Web of Science ®Google Scholar